Multivariable regression models of forced expiratory volume in 1 s (FEV1) % pred in the cystic fibrosis (CF) group
Model | Group | Model of | Age (years) | Chronic Pseudomonas aeruginosa# | Sex (female) | Sweat chloride (mmol·L−1) | HNE ASL FRAP | Model | |||||||
β1 | p-value | β2 | p-value | β3 | p-value | β4 | p-value | β5 | p-value | R2 | p-value | β0 | |||
1 | CF | FEV1 % pred (n=25) | −1.1 | 0.001 | −22.7 | 0.007 | −10.9 | 0.12 | −0.26 | 0.05 | 0.66 | <0.0001 | 145 | ||
2 | CF | FEV1 % pred (n=10)¶ | −0.85 | 0.11 | −30.0 | 0.09 | −27.8 | 0.03 | −0.21 | 0.45 | −13.8 | 0.02 | 0.91 | 0.01 | 187 |
3 | CF | FEV1 % pred (n=10)¶ | −1.1 | 0.09 | −7.95 | 0.70 | −24.8 | 0.07 | −0.25 | 0.57 | 0.76 | 0.03 | 142 |
MCC: mucociliary clearance; P. aeruginosa: Pseudomonas aeruginosa; HNE: human nasal epithelial; ASL: airway surface liquid; FRAP: fluorescence recovery after photobleaching. FEV1 % pred=β1(age)+β2(P. aeruginosa)+β3(sex)+β4(sweat chloride)+β5(FRAP)+β0. #: chronic P. aeruginosa is defined as two or more positive throat or sputum cultures in the previous year; ¶: only a portion of the CF group had FRAP measurements available (n=10).